|Bid||118.85 x 1100|
|Ask||119.09 x 800|
|Day's range||117.88 - 121.74|
|52-week range||116.60 - 180.36|
|Beta (5Y monthly)||1.25|
|PE ratio (TTM)||30.37|
|Earnings date||07 Feb 2022|
|Forward dividend & yield||0.96 (0.80%)|
|Ex-dividend date||27 Dec 2021|
|1y target est||158.00|
Smith+Nephew's (SNN) acquisition of Engage Surgical reinforces its growth strategy while expanding its Orthopaedic Reconstruction product line.
Abbott (ABT) delivered earnings and revenue surprises of 11.86% and 8.52%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
The third quarter brings greater COVID-related pressure than expected for Zimmer Biomet (ZBH).